Home
>
National Drug Code (NDC)
>
Quinidine Sulfate
Quinidine Sulfate - 0093-9175-52 - (Quinidine Sulfate)
Drug Information of Quinidine Sulfate
| Product NDC: | 0093-9175 |
| Proprietary Name: | Quinidine Sulfate |
| Non Proprietary Name: | Quinidine Sulfate |
| Active Ingredient(s): | 300 mg/1 & nbsp; Quinidine Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Quinidine Sulfate
| Product NDC: | 0093-9175 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040045 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950101 |
Package Information of Quinidine Sulfate
| Package NDC: | 0093-9175-52 |
| Package Description: | 250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-9175-52) |
NDC Information of Quinidine Sulfate
| NDC Code | 0093-9175-52 |
| Proprietary Name | Quinidine Sulfate |
| Package Description | 250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-9175-52) |
| Product NDC | 0093-9175 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quinidine Sulfate |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19950101 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | QUINIDINE SULFATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |
